CN116617328A - Traditional Chinese medicine composition for treating coronary heart disease stable angina pectoris phlegm-blood stasis syndrome - Google Patents
Traditional Chinese medicine composition for treating coronary heart disease stable angina pectoris phlegm-blood stasis syndrome Download PDFInfo
- Publication number
- CN116617328A CN116617328A CN202310695231.8A CN202310695231A CN116617328A CN 116617328 A CN116617328 A CN 116617328A CN 202310695231 A CN202310695231 A CN 202310695231A CN 116617328 A CN116617328 A CN 116617328A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- decoction
- heart disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明涉及中医药领域,尤其涉及用于治疗冠心病稳定性心绞痛痰瘀互结证的中药组合物。The invention relates to the field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating coronary heart disease with stable angina pectoris and syndrome of intertwined phlegm and blood stasis.
背景技术Background technique
冠状动脉粥样硬化性心脏病(简称冠心病)是指由于冠状动脉粥样硬化使管腔狭窄或闭塞导致心肌缺血、缺氧或坏死而引发的心脏疾病。目前,临床上将冠心病分为慢性心肌缺血综合征和急性冠状动脉综合征,前者又被称为稳定性冠心病,其最具代表性的病种是稳定性心绞痛。Coronary atherosclerotic heart disease (coronary heart disease for short) refers to a heart disease caused by myocardial ischemia, hypoxia or necrosis due to narrowing or occlusion of the lumen due to coronary atherosclerosis. At present, coronary heart disease is clinically divided into chronic myocardial ischemia syndrome and acute coronary syndrome. The former is also called stable coronary heart disease, and its most representative disease is stable angina pectoris.
2017年全球疾病负担国际合作研究发布的数据表明,冠心病是全球第一位的死亡原因。规范的药物治疗显著地改善了患者的生活质量和远期预后,然而,冠心病危险因素较多,病理生理过程复杂,西药治疗靶点单一,很难对疾病进行全方位的干预,以及部分患者不能耐受药物治疗的副作用。According to the data released by the International Cooperative Research on Global Burden of Disease in 2017, coronary heart disease is the number one cause of death in the world. Standardized drug treatment has significantly improved the quality of life and long-term prognosis of patients. However, there are many risk factors for coronary heart disease, the pathophysiological process is complex, and the target of Western medicine is single, so it is difficult to intervene in all aspects of the disease, and some patients Intolerable side effects of drug therapy.
冠心病属于中医学“胸痹心痛”的范畴,以“阳微阴弦”为基本病机,是本虚标实之证,其中,本虚涉及气虚、血虚、阴虚和阳虚;标实包括寒凝、气滞、血瘀、痰浊。临床调查资料显示,痰瘀互结证已成为稳定性心绞痛的主要临床证型之一。如果不积极干预,将极大影响国民的生活质量和预期寿命,同时增加治疗疾病的经济负担。Coronary heart disease belongs to the category of "chest pain and heart pain" in traditional Chinese medicine, with "Yang Wei Yin string" as the basic pathogenesis, and it is a syndrome of deficiency in origin and excess in excess. Among them, deficiency in origin involves qi deficiency, blood deficiency, yin deficiency and yang deficiency; Reality includes cold coagulation, qi stagnation, blood stasis, phlegm turbidity. According to clinical investigation data, the syndrome of mixed phlegm and blood stasis has become one of the main clinical syndromes of stable angina pectoris. If there is no active intervention, it will greatly affect the quality of life and life expectancy of the people, and at the same time increase the economic burden of disease treatment.
发明内容Contents of the invention
本发明意在提供一种用于治疗冠心病稳定性心绞痛痰瘀互结证的中药组合物,全方配伍严谨,共同发挥“化痰宣痹,祛瘀通络”之功效,对冠心病稳定性心绞痛痰瘀互结证的治疗效果显著,副作用小。The present invention intends to provide a traditional Chinese medicine composition for the treatment of stable angina pectoris with phlegm and blood stasis syndrome in coronary heart disease. The therapeutic effect of angina pectoris with mixed phlegm and blood stasis syndrome is remarkable, and the side effects are small.
本发明提供如下技术方案:The present invention provides following technical scheme:
用于治疗冠心病稳定性心绞痛痰瘀互结证的中药组合物,由如下重量份的药材组成:瓜蒌1~8份,薤白1~4份,枳壳1~4份,桂枝1~3份,茯苓1~3份,桃仁1~3份,牡丹皮1~3份,赤芍1~3份。The traditional Chinese medicine composition for treating stable angina pectoris of coronary heart disease with phlegm-stasis intertwining syndrome consists of the following medicinal materials in parts by weight: 1-8 parts of Trichosanthes mellifera, 1-4 parts of Scallops, 1-4 parts of Citrus aurantium, 1-4 parts of Guizhi 3 parts, 1-3 parts of poria cocos, 1-3 parts of peach kernel, 1-3 parts of Moutan bark, 1-3 parts of red peony root.
进一步的,所述中药组合物由如下重量份的药材组成:瓜蒌6份,薤白3份,枳壳3份,桂枝2份,茯苓2份,桃仁2份,牡丹皮2份,赤芍2份。Further, the traditional Chinese medicine composition is composed of the following medicinal materials in parts by weight: 6 parts of fennel, 3 parts of scallion, 3 parts of citrus aurantium, 2 parts of cassia twig, 2 parts of poria cocos, 2 parts of peach kernel, 2 parts of Moutan bark, and red peony 2 servings.
本发明的另一目的在于提供所述中药组合物在制备用于治疗冠心病稳定性心绞痛痰瘀互结证的药物中的应用。Another object of the present invention is to provide the application of the traditional Chinese medicine composition in the preparation of medicines for treating stable angina pectoris of coronary heart disease with intertwined phlegm and blood stasis syndrome.
本发明的另一目的在于提供一种治疗冠心病稳定性心绞痛痰瘀互结证的药物,以所述中药组合物为原料,包括或不包括药学上可以接受的辅料,通过本领域常规的方法制备成临床上可以接受的制剂。Another object of the present invention is to provide a medicine for treating stable angina pectoris with phlegm and blood stasis syndrome of coronary heart disease, using the traditional Chinese medicine composition as a raw material, including or not including pharmaceutically acceptable excipients, through conventional methods in the field Prepared into clinically acceptable preparations.
进一步的,所述制剂为汤剂或颗粒制剂。Further, the preparation is decoction or granule preparation.
进一步的,所述汤剂的制作方法包括以下步骤:Further, the preparation method of described decoction comprises the following steps:
将中药原料洗净后与水混合,浸泡后煎煮,过滤,得到第一药渣和第一汤药;Washing the raw materials of the traditional Chinese medicine, mixing with water, soaking, decocting, and filtering to obtain the first medicinal residue and the first decoction;
将所述第一药渣与水混合,煎煮,过滤,得到第二药渣和第二汤药;mixing the first medicinal residues with water, decocting, and filtering to obtain the second medicinal residues and the second decoction;
将所述第一汤药和第二汤药混合,得到汤剂。Mix the first decoction and the second decoction to obtain a decoction.
进一步的,制作汤剂时,所述中药原料的总质量与水混合的质量比为1:10,所述浸泡时间为30~60min;所述煎煮为先用武火煮沸,再用文火煎煮30~60min;所述第一药渣与水混合的质量比为1:5。Further, when making the decoction, the mass ratio of the total mass of the traditional Chinese medicine raw materials to water is 1:10, and the soaking time is 30-60 minutes; 30-60 minutes; the mass ratio of the first medicinal residues to water is 1:5.
瓜蒌:味甘、微苦,性寒,归肺、胃、大肠经。《本草经集注》:“主胸痹,悦泽人面。茎叶,治中热伤暑”。《长沙药解》:“味甘、微苦、微寒,入手太阴肺经。清心润肺,洗垢除烦,开胸膈之痹结,涤涎沫之胶黏,最洗瘀浊,善解懊憹”。药理研究表明,瓜蒌能扩张冠状动脉,增加冠脉血流,较大剂量时,能抑制心脏,降低心肌收缩力,减慢心率,瓜蒌能提高动物的耐缺氧能力。瓜蒌所含的栝楼酸能抑制血小板聚集。Gualou: Sweet in taste, slightly bitter, cold in nature, returns to lung, stomach and large intestine meridian. "Compendium of Materia Medica": "The main chest pain, Yueze people's face. The stems and leaves are used to treat heat and summer heat." "Changsha Yaojie": "It tastes sweet, slightly bitter, and slightly cold, and it starts with the Taiyin Lung Meridian. It clears the heart and moistens the lungs, washes away dirt and troubles, opens the numbness of the chest and diaphragm, washes away the stickiness of saliva, and cleanses turbidity best. Relieve regret". Pharmacological studies have shown that Trichosanthes can dilate coronary arteries and increase coronary blood flow. In larger doses, it can inhibit the heart, reduce myocardial contractility, and slow down heart rate. Trichosanthes can improve the hypoxia tolerance of animals. Trichosanthenic acid contained in Trichosanthes can inhibit platelet aggregation.
薤白:味辛、苦,性温,归大肠经。《神农本草经》:“味辛,温。主金疮,疮败。轻身,不饥,耐老”。《长沙药解》:“味辛,气温,入手太阴肺、手阳明大肠经。开胸痹而降逆,除后重而升陷,最消痞痛,善止滑泄”。药理研究表明,薤白乙醇浸膏具有抗血小板聚集、降低血脂、抗动脉粥样硬化、抗氧化和抗炎等作用。Xie Bai: pungent in taste, bitter, warm in nature, returns to the large intestine meridian. "Shen Nong's Materia Medica": "It tastes pungent and warm. It is mainly used for gold sores and sores. Light body, not hungry, and resistant to old age." "Changsha Yaojie": "Pungent in taste, warm in temperature, starts with Taiyin Lung and Hand Yangming Large Intestine Meridian. Opens chest obstruction and lowers adverse events, removes heavy and ascends depression, best relieves swelling and pain, and is good at stopping slippery diarrhea." Pharmacological studies have shown that the ethanol extract of Xiebai has the effects of anti-platelet aggregation, lowering blood lipid, anti-atherosclerosis, anti-oxidation and anti-inflammation.
枳壳:味苦、辛、酸,性温,归脾、胃经。《雷公炮制药性解》:“味辛苦酸,性微寒,无毒,入肺、肝、胃、大肠四经。主下胸中至高之气,消心中痞塞之痰,泄腹中滞塞之气,去胃中隔宿之食,削腹内连年之积,疏皮毛胸膈之病,散风气痒麻,通大肠闭结,止霍乱,疗肠风,攻痔疾,消水肿,除风痛。去瓤核,麸炒用,陈久者良”。药理研究表明,枳壳具有调节胃肠功能、降血脂等作用。Citrus aurantium: bitter in taste, pungent, sour, warm in nature, returns spleen, stomach meridian. "Leigong Pao Medicine Properties Solution": "It tastes bitter and sour, slightly cold in nature, non-toxic, enters the four meridians of lung, liver, stomach, and large intestine. It controls the highest qi in the lower chest, eliminates the phlegm in the heart, and vents the stagnation in the abdomen. Qi, remove the food in the middle of the stomach, reduce the accumulated accumulation in the abdomen for many years, relieve the disease of skin, hair, chest and diaphragm, dispel wind-qi, itching and numbness, unblock the large intestine, relieve cholera, treat intestinal wind, attack hemorrhoids, eliminate edema, and relieve wind pain .Remove the flesh and core, stir-fry the bran, good for a long time.” Pharmacological studies have shown that Fructus Aurantii has the functions of regulating gastrointestinal function and lowering blood fat.
桂枝:味辛,温。《本草经集注》:“味辛,温,无毒。主治上气咳逆,结气,喉痹,吐吸。心痛,胁风,胁痛,温筋通脉,止烦出汗,利关节,补中益气。久服通神,轻身,不老”。《长沙药解》:“味甘、辛,气香,性温。入足厥阴肝、足太阳膀胱经。入肝家而行血分,走经络而达营郁,善解风邪,最调木气,升清阳脱陷,降浊阴冲逆,舒筋脉之急挛,利关节之壅阻,入肝胆而散遏抑,极止痛楚,通经络而开痹涩,甚去湿寒,能止奔豚,更安惊悸”。药理研究表明,桂枝所含的桂皮油能扩张血管,改善血液循环。此外,桂枝还有抗炎、增减冠脉血流量和改善心功能等作用。Cinnamomum twig: acrid in the mouth, warm. "Compendium of Materia Medica": "Spicy, warm, non-toxic. Indications for upper Qi cough, stagnation, sore throat, vomiting and inhalation. Heartache, hypochondriac pain, hypochondriac pain, warming tendons, dredging veins, relieving restlessness and sweating, sharpening joints, Tonify the middle and replenish qi. Take it for a long time to improve the mind, lighten the body, and not grow old." "Changsha Yaojie": "It tastes sweet, pungent, fragrant, and warm in nature. It enters the liver of the foot Jueyin and the bladder meridian of the foot sun. It enters the liver to circulate the blood, and goes through the meridians to reach the stagnation of the camp. Regulate wood qi, elevate clear yang and relieve depression, reduce turbidity and yin, reverse and reverse, relax tendons and arteries, sharpen joint blockage, enter liver and gallbladder to dissipate and restrain, extremely relieve pain, dredge meridians and collaterals, relieve numbness and astringency, and even remove dampness and cold , can stop running dolphin, more peace of mind." Pharmacological studies have shown that cinnamon oil contained in cassia twigs can dilate blood vessels and improve blood circulation. In addition, cinnamon twigs also have anti-inflammatory effects, increase or decrease coronary blood flow, and improve heart function.
茯苓:味甘、淡,性平,归心肺脾肾经。《神农本草经》:“味甘,平。主胸胁逆气,忧恚,惊邪,恐悸,心下结痛,寒热烦满,咳逆,口焦舌干,利小便。久服安魂养神,不饥,延年”。《长沙药解》:“味甘,气平,入足阳明胃、足太阴脾、足少阴肾、足太阳膀胱经。利水燥土,泻饮消痰,善安悸动,最豁郁满。除汗下之烦躁,止水饮之燥渴,淋癃泄痢之神品,崩漏遗带之妙药,气鼓与水胀皆灵,反胃共噎膈俱效。功标百病,效著千方”。药理研究表明,茯苓主要含三萜类和多糖类2种化合物,具有利尿、抗炎和增加心肌收缩力等作用。Poria cocos: sweet in taste, light in taste, flat in nature, returns to the heart, lung, spleen and kidney channels. "Shen Nong's Materia Medica": "Taste sweet, flat. Administers adverse qi in the chest and hypochondrium, anxiety, shock, palpitations, pain in the heart, cold and heat, irritability, cough, burning mouth and tongue, diuresis. Take it for a long time Replenish the soul, nourish the mind, not be hungry, and prolong life." "Changsha Yaojie": "Sweet in taste, calm in Qi, enters the stomach of foot Yangming, spleen of foot Taiyin, kidney of foot Shaoyin, and bladder of foot Taiyang. It can diure water and dry soil, relieve drink and eliminate phlegm, be good for throbbing and relieve depression. Fullness. Eliminates irritability under sweating, relieves dryness and thirst with drinking water, a magic product for phlegm and dysentery, a wonderful medicine for metrorrhagia and metrorrhagia. Effective in a thousand ways." Pharmacological studies have shown that Poria cocos mainly contains two compounds, triterpenoids and polysaccharides, which have diuretic, anti-inflammatory and increased myocardial contractility effects.
桃仁:味苦、甘,性平。《神农本草经》:“苦,平。主瘀血,血闭,癥瘕,邪气。杀小虫”。《雷公炮制药性解》:“味苦甘,性平,无毒。入肝、大肠二经,主瘀血血闭,癥瘕鬼邪,血燥便结,杀三虫,止心痛”。药理研究表明,桃仁水提物、苦杏仁苷、桃仁脂肪能抑制血小板聚集。Peach kernel: bitter, sweet, flat in nature. "Shen Nong's Materia Medica": "Bitter, flat. Main blood stasis, blood stasis, lump in the abdomen, evil spirit. Kill small insects." "Lei Gong Pao Medicinal Properties Solution": "Bitter and sweet, flat in nature, non-toxic. It enters the liver and large intestine two meridians, and controls blood stasis and blood closure, lumps in the abdomen, ghost evil, blood dryness and stool knot, kills three insects, and relieves heartache." Pharmacological studies have shown that peach kernel water extract, amygdalin, and peach kernel fat can inhibit platelet aggregation.
牡丹皮:味苦、辛,性微寒。《神农本草经》:“味辛,寒。主寒热,中风瘈疭,痉,惊痫邪气,除癥瘕,瘀血留舍肠胃。安五脏,疗痈创”。《长沙药解》:“味苦、辛,微寒,入足厥阴肝经。达木郁而清风,行瘀血而泻热,排痈疽之脓血,化脏腑之癥瘕”。药理研究表明,牡丹皮具有抗心肌缺血、抗动脉粥样硬化、调节心律失常和降压等作用。Cortex Moutan: bitter, pungent, slightly cold in nature. "Shen Nong's Materia Medica": "Pungent, cold. Mainly cold and heat, stroke, convulsions, convulsions, convulsions, epilepsy, evil spirits, symptom removal, blood stasis and left in the stomach. Soothe the five internal organs, treat carbuncle wounds." "Changsha Yaojie": "bitter, pungent, slightly cold, enters the Liver Meridian of Foot Jueyin. Relieves wood stagnation and cools the wind, promotes blood stasis and relieves heat, expels pus and blood of carbuncle and gangrene, and transforms abdominal mass in viscera." Pharmacological studies have shown that Cortex Moutan has the functions of anti-myocardial ischemia, anti-atherosclerosis, regulating arrhythmia and lowering blood pressure.
赤芍:味苦,性微寒。《神农本草经》:“味苦,平。主邪气腹痛,除血痹,破坚积,寒热,疝瘕,止痛,利小便,益气”。《本草经解》:“《本经》不分赤白,东垣云:赤者利小便下气,白者止痛散气血。俗云:白补赤泻。《本草纲目》云:白芍益脾,能于土中泻木,赤芍散邪,能行血中之滞,产后气血已虚,不可更泻,故禁用,非仅以其酸寒也。日华子谓:主女人一切病.并及产后用宜酒炒。愚意不若勿用为稳”。药理研究表明,赤芍具有抗血小板聚集、抗血栓形成、抗心肌缺血、改善微循环和抗氧化等作用。Radix Paeoniae Rubra: Bitter in the mouth, slightly cold in nature. "Shen Nong's Materia Medica": "Bitter taste, flat. Mainly evil abdominal pain, eliminate blood numbness, break hard accumulation, cold and heat, hernia, relieve pain, facilitate urination, and replenish qi." "Book of Materia Medica": ""Book of Materia Medica" does not distinguish between red and white. Dongyuan said: the red one can benefit the urine and lower the qi, and the white one can relieve pain and disperse qi and blood. The common saying: white tonic and red diarrhea. "Compendium of Materia Medica" says: white peony root to benefit the spleen , can expel wood in the soil, red peony disperses evil, and can promote stagnation in blood. Postpartum qi and blood are deficient and cannot be more diarrhea. .And stir-fry with suitable wine after giving birth. If you are not stupid, don't use it for stability." Pharmacological studies have shown that Radix Paeoniae Rubra has anti-platelet aggregation, anti-thrombosis, anti-myocardial ischemia, improvement of microcirculation and anti-oxidation effects.
本方的有益效果:Beneficial effects of this side:
枳实薤白桂枝汤和桂枝茯苓丸均来自中医经典著作《金匮要略》,前者治疗胸痹心痛病的高效方,而后者素有“东方的阿司匹林”之称。瓜蒌薤白桂枝汤由上述两方化裁而来,其药物组成为:瓜蒌、薤白、枳壳、桂枝、茯苓、桃仁、牡丹皮和赤芍。冠心病属于中医“胸痹心痛”的范畴,本虚标实是其主要病机,临床证素主要包括气虚、血虚、阴虚、阳虚、寒凝、气滞、血瘀和痰浊。临床研究表明,随着居民不良生活方式的流行,痰瘀互结证已成为稳定性心绞痛的主要证型之一。瓜蒌,涤痰散结,开胸通痹;桃仁,活血通络,祛瘀止痛,与瓜蒌共为君药。薤白,通阳散结,宣痹降逆,能化上焦结聚之痰浊,宣胸中结气以宽胸;牡丹皮、赤芍,活血通络,增强桃仁祛瘀之功;薤白、牡丹皮、赤芍合用,增强君药涤痰祛瘀之效,是为臣药。痰浊和瘀血,乃有形实邪,易阻滞人体气机。枳壳,能下胸中至高之气,消心中痞塞之痰,泄腹中滞塞之气,去胃中隔宿之食,削腹内连年之积,疏皮毛胸膈之病,是为使药。血不利则为水,茯苓,利水消痰渗湿,与活血药同用,发挥血水同治之功,是为使药。本方源于经典,药物配伍严谨,诸药合用,共奏“涤痰祛瘀,通络止痛”之效。Zhishi Xiebai Guizhi Decoction and Guizhi Fuling Pills are both from the classic Chinese medicine book "Synopsis of the Golden Chamber". The former is a highly effective prescription for treating chest pain and heartache, while the latter is known as "Oriental Aspirin". Gualou Xiebai Guizhi Decoction is made from the above two prescriptions. Its medicines are: Gualou, Xiebai, Citrus aurantium, Guizhi, Poria, peach kernel, moutan bark and red peony root. Coronary heart disease belongs to the category of "chest obstruction and heart pain" in traditional Chinese medicine. Deficiency in origin and excess in superficiality are its main pathogenesis. Clinical syndromes mainly include qi deficiency, blood deficiency, yin deficiency, yang deficiency, cold coagulation, stagnation of qi, blood stasis and phlegm turbidity. Clinical studies have shown that with the prevalence of unhealthy lifestyles among residents, the syndrome of intertwined phlegm and blood stasis has become one of the main syndromes of stable angina. Gualou, clears phlegm and dissipates stagnation, opens the chest and unblocks numbness; peach kernel, promotes blood circulation and dredges collaterals, dispels blood stasis and relieves pain, and together with Gualou is a king drug. Scallions, clearing yang and dispelling stagnation, dispelling numbness and subduing adverse events, can dissolve phlegm turbidity accumulated in the upper energizer, relieve qi stagnation in the chest to widen the chest; moutan bark, red peony root, promote blood circulation and dredge collaterals, enhance the power of peach kernels to remove blood stasis; scallions, peonies Cortex and Radix Paeoniae Rubra are used in combination to enhance the effect of the monarch drug for clearing phlegm and removing blood stasis, and it is a ministerial drug. Phlegm turbidity and blood stasis are tangible evils that can easily block the body's Qi. Citrus aurantii, can lower the highest Qi in the chest, relieve the phlegm of the fullness in the heart, vent the stagnant Qi in the abdomen, remove the food in the stomach, reduce the accumulation of years in the abdomen, and thin the skin, hair, and chest. medicine. If the blood is unfavorable, then it is water, Poria cocos, diuresis, eliminating phlegm and expelling dampness, used together with blood-activating medicine, bringing into play the merit of treating blood and water together, is to make medicine. This prescription is derived from classics, and the compatibility of drugs is strict. The combination of various drugs has the effect of "eliminating phlegm and blood stasis, dredging collaterals and relieving pain".
具体实施方式Detailed ways
下面结合具体实施案例说明本技术方案。The technical solution will be described below in conjunction with specific implementation examples.
实施例1:Example 1:
一种用于治疗冠心病稳定性心绞痛痰瘀互结证的中药组合物,选用中药原料按重量配比可以为:瓜蒌6份、薤白3份、枳壳3份、桂枝2份、茯苓2份、桃仁2份、牡丹皮2份及赤芍2份,每份5g。A traditional Chinese medicine composition for treating stable angina pectoris of coronary heart disease with phlegm and blood stasis syndrome. 2 parts, 2 parts of peach kernel, 2 parts of Moutan bark and 2 parts of red peony root, 5g each.
将上述中药原料洗净,一起放入容器浸泡30min后煎煮,武火煮沸后,改用文火煎煮30min,倒出药汁,煎煮两次,将两次药汁混合后,分3次饭后服用,1个月为1疗程,一般治疗1-3疗程。Wash the above-mentioned Chinese medicine raw materials, put them into a container and soak for 30 minutes, and then decoct them. After taking it, 1 month is a course of treatment, generally 1-3 courses of treatment.
实施例2:Example 2:
一种用于治疗冠心病稳定性心绞痛痰瘀互结证的中药组合物,选用中药原料按重量配比可以为:瓜蒌6份、薤白3份、枳壳3份、桂枝2份、茯苓2份、桃仁2份、牡丹皮2份及赤芍2份,每份5g。A traditional Chinese medicine composition for treating stable angina pectoris of coronary heart disease with phlegm and blood stasis syndrome. 2 parts, 2 parts of peach kernel, 2 parts of Moutan bark and 2 parts of red peony root, 5g each.
各个中药采用全成分颗粒剂,按上述重量配比,将所得的全成分颗粒剂充分混合后,分为3等份。每日3次,每次1份,饭后开水冲服,1个月为1疗程,一般治疗1-3疗程。Each traditional Chinese medicine adopts full-ingredient granules, and according to the above weight ratio, the obtained full-ingredient granules are fully mixed and then divided into 3 equal parts. 3 times a day, 1 serving each time, take with boiled water after meal, 1 month is 1 course of treatment, generally 1-3 courses of treatment.
病例一case one
张某,男,67岁,体重指数26.52kg/m2。主诉:间断胸痛6年余,加重1周。患者曾于2015年因胸痛行冠脉造影检查提示:前降支近中段重度狭窄,第1对角支近段中度狭窄,回旋支近段中度狭窄,右冠近段中度狭窄,术中于前降支置入支架2枚,术后规范服药治疗,心率、血脂控制达标。近1周来,患者于活动中再次出现心前区闷痛感,伴气短,休息后可自行缓解,阵发头昏,食欲佳,夜寐可,小便可,大便稀。舌质暗红,舌下络脉迂曲,苔白润。脉沉弦。既往有“2型糖尿病、高血压病3级”病史。西医诊断为:冠心病-稳定性心绞痛-冠脉支架置入术后状态,中医诊断为:胸痹心痛病(痰瘀互结证)。处方以瓜蒌6份、薤白3份、枳壳3份、桂枝2份、茯苓2份、桃仁2份、牡丹皮2份及赤芍2份,每份5g。嘱在规范西医治疗基础上,服用上述处方7付,服药期间禁食肥甘厚腻之品。复诊时,患者诉胸痛发作次数减少,无头昏,继续予上方14付。Zhang, male, 67 years old, body mass index 26.52kg/m 2 . Chief complaint: intermittent chest pain for more than 6 years, aggravated for 1 week. The patient underwent coronary angiography in 2015 due to chest pain, which indicated: severe stenosis in the proximal and middle sections of the anterior descending artery, moderate stenosis in the proximal section of the first diagonal branch, moderate stenosis in the proximal section of the circumflex branch, and moderate stenosis in the proximal section of the right coronary artery. Two stents were implanted in the anterior descending artery, and medication was prescribed after the operation, and heart rate and blood lipids were controlled up to standard. In the past 1 week, the patient experienced precordial pain again during activities, accompanied by shortness of breath, which can be relieved by itself after rest. Body of the tongue is dark red, sublingual collaterals are tortuous, and the fur is white and moist. Deep pulse. He had a history of "type 2 diabetes and hypertension grade 3" in the past. The western medicine diagnosis is: coronary heart disease-stable angina pectoris-coronary stent implantation postoperative state, and the traditional Chinese medicine diagnosis is: chest obstruction and heart pain (syndrome of intertwined phlegm and blood stasis). The prescription consists of 6 parts of Gualou, 3 parts of Scallops, 3 parts of Citrus aurantii, 2 parts of Guizhi, 2 parts of Poria cocos, 2 parts of peach kernel, 2 parts of Moutan bark and 2 parts of red peony root, 5g each. Advise on the basis of standard western medicine treatment, take 7 pairs of above-mentioned prescriptions, during the period of taking the medicine, fasting fat, sweet, thick and greasy products. During follow-up consultation, the patient complained that the number of episodes of chest pain decreased, without dizziness, and continued to give the upper 14 doses.
病例二case two
熊某,女,64岁,体重指数24.97kg/m2。主诉:胸痛1月。患者近1个多月以来,反复出现心前区闷痛感,与活动相关,伴头昏、气短、乏力,休息后可逐渐缓解,曾行冠脉造影提示前降支中段中重度狭窄,约70%,因拒绝行支架置入术,平时服用阿司匹林肠溶片、阿托伐他汀钙片、琥珀酸美托洛尔缓释片、单硝酸异山梨酯缓释片等药物。舌质暗红,苔白腻,脉沉迟。双下肢肌肤甲错。西医诊断为:稳定性心绞痛,中医诊断为:胸痹心痛病(痰瘀互结证)。处方以瓜蒌7份、薤白3份、枳壳3份、桂枝2份、茯苓2份、桃仁2份、牡丹皮2份及赤芍2份,每份5g。嘱在规范西医治疗基础上,并予上方14付,服药期间禁食肥甘厚腻之品。复诊时,患者诉近日来无明显胸痛发作,嘱继续服用中药治疗,予上述处方14付。Xiong, female, 64 years old, body mass index 24.97kg/m 2 . Chief complaint: Chest pain for 1 month. For more than a month, the patient has repeatedly experienced dull pain in the precordial area, which is related to activities, accompanied by dizziness, shortness of breath, and fatigue. %, because he refused to perform stent placement, he usually took aspirin enteric-coated tablets, atorvastatin calcium tablets, metoprolol succinate sustained-release tablets, isosorbide mononitrate sustained-release tablets and other drugs. The body of the tongue is dark red, the coating is white and greasy, and the pulse is deep and slow. The skin of the lower extremities is wrong. Western medicine diagnosis is: stable angina pectoris, and Chinese medicine diagnosis is: chest obstruction and heart pain (syndrome of mutual accumulation of phlegm and blood stasis). The prescription consists of 7 parts of Gualou, 3 parts of Scallops, 3 parts of Citrus aurantii, 2 parts of Guizhi, 2 parts of Poria cocos, 2 parts of peach kernel, 2 parts of Moutan bark and 2 parts of red peony root, 5g each. Advise on the basis of standardized Western medicine treatment, and give the top 14 pays, fasting fat, sweet and thick greasy products during the medication. During follow-up consultation, the patient complained that there was no obvious chest pain outbreak in recent days, advised to continue to take traditional Chinese medicine treatment, and gave 14 of the above prescriptions.
病例三case three
余某,男,77岁,体重指数34.16kg/m2。主诉:间断胸痛9年余,再发2天。患者于2013开始出现间断胸痛,与活动相关,休息后可逐渐缓解,未予重视。2017年,因突发胸痛,持续不缓解,后就诊于医院,诊断为急性下壁心肌梗死,行急诊冠脉造影提示右冠中段闭塞,前降支近段中度狭窄,术中于右冠闭塞处置入支架1枚,术后坚持服药,血脂控制不达标。近2天来,患者再次出现胸骨后中段不适,与活动相关,含服硝酸甘油后可缓解,伴心慌、乏力,时有恶心,食欲不振,纳少,多眠睡,二便尚可。口唇色暗,舌质暗红,舌下瘀斑,苔白腻。脉沉迟。西医诊断为:陈旧性心肌梗死-稳定性心绞痛-冠脉支架置入术后状态,中医诊断为:胸痹心痛病(痰瘀互结证)。处方以瓜蒌7份-、薤白3份、枳壳3份、桂枝2份、茯苓2份、桃仁2份、牡丹皮2份及赤芍2份。嘱在规范西医治疗基础上,并予上方14付,服药期间禁食肥甘厚腻之品。复诊时,患者诉服药后时有胸痛,持续时间缩短,硝酸甘油使用量减少,乏力感减轻,纳可,多眠睡,二便尚可,继续予上方14付。再次复诊时,患者诉胸痛偶有发作,休息后可自行缓解,自觉精神佳,纳可,夜寐安,二便尚可。舌质暗红,苔薄白,舌下可见瘀斑,脉沉迟。嘱续服上方14付。Yu, male, 77 years old, body mass index 34.16kg/m 2 . Chief complaint: intermittent chest pain for more than 9 years, recurring for 2 days. The patient began to experience intermittent chest pain in 2013, which was related to activities and gradually relieved after rest, which was not taken seriously. In 2017, due to sudden chest pain that persisted and did not relieve, he went to the hospital and was diagnosed with acute inferior wall myocardial infarction. Emergency coronary angiography showed that the middle segment of the right coronary artery was occluded, and the proximal segment of the anterior descending artery was moderately narrowed. One stent was placed in the occlusion treatment, and the medication was continued after the operation, but the blood lipid control was not up to standard. In the past 2 days, the patient experienced discomfort in the mid-section of the retrosternum again, which was related to activities and could be relieved after taking nitroglycerin. It was accompanied by palpitation, fatigue, nausea from time to time, loss of appetite, lack of appetite, excessive sleepiness, and two stools were okay. Dark lips, dark red tongue, sublingual ecchymosis, white and greasy fur. Slow pulse. The western medicine diagnosis is: old myocardial infarction-stable angina pectoris-coronary stent implantation postoperative state, and the traditional Chinese medicine diagnosis is: chest obstruction and heart pain (syndrome of intertwined phlegm and blood stasis). The prescription consists of 7 parts of Gualou, 3 parts of Allium, 3 parts of Citrus aurantium, 2 parts of Guizhi, 2 parts of Poria, 2 parts of peach kernel, 2 parts of Moutan bark and 2 parts of red peony. Advise on the basis of standardized Western medicine treatment, and give the top 14 pays, fasting fat, sweet and thick greasy products during the medication. During the follow-up consultation, the patient complained of chest pain after taking the medicine, the duration was shortened, the consumption of nitroglycerin was reduced, and the feeling of fatigue was relieved. At the next follow-up visit, the patient complained of occasional episodes of chest pain, which could be relieved by itself after rest, and felt that he was in good spirits. The body of the tongue is dark red, the fur is thin and white, ecchymosis can be seen under the tongue, and the pulse is deep and slow. Order to continue taking the top 14 payment.
服药期间注意事项:禁食肥甘厚腻之品,禁食冷饮,戒烟戒酒,避免熬夜,坚持运动锻炼,每周3~5次。Precautions while taking the medicine: fasting of fatty, sweet and greasy products, fasting of cold drinks, quitting smoking and drinking, avoid staying up late, insist on exercising, 3 to 5 times a week.
以上所述的仅是本发明的实施例,方案中公知的具体技术方案和/或特性等常识在此未作过多描述。应当指出,对于本领域的技术人员来说,在不脱离本发明技术方案的前提下,还可以作出若干变形和改进,这些也应该视为本发明的保护范围,这些都不会影响本发明实施的效果和专利的实用性。本申请要求的保护范围应当以其权利要求的内容为准,说明书中的具体实施方式等记载可以用于解释权利要求的内容。What is described above is only an embodiment of the present invention, and common knowledge such as specific technical solutions and/or characteristics known in the solutions will not be described here too much. It should be pointed out that for those skilled in the art, without departing from the technical solutions of the present invention, some modifications and improvements can also be made, which should also be regarded as the protection scope of the present invention, and these will not affect the implementation of the present invention effect and utility of the patent. The scope of protection required by this application shall be based on the content of the claims, and the specific implementation methods and other records in the specification may be used to interpret the content of the claims.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310695231.8A CN116617328A (en) | 2023-06-13 | 2023-06-13 | Traditional Chinese medicine composition for treating coronary heart disease stable angina pectoris phlegm-blood stasis syndrome |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310695231.8A CN116617328A (en) | 2023-06-13 | 2023-06-13 | Traditional Chinese medicine composition for treating coronary heart disease stable angina pectoris phlegm-blood stasis syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116617328A true CN116617328A (en) | 2023-08-22 |
Family
ID=87617061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310695231.8A Pending CN116617328A (en) | 2023-06-13 | 2023-06-13 | Traditional Chinese medicine composition for treating coronary heart disease stable angina pectoris phlegm-blood stasis syndrome |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116617328A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116270885A (en) * | 2023-05-11 | 2023-06-23 | 中国人民解放军陆军第八十二集团军医院 | Traditional Chinese medicine composition for treating phlegm stagnation type coronary heart disease and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105832978A (en) * | 2016-04-21 | 2016-08-10 | 北京祥和康健科技发展有限公司 | Traditional Chinese medicine composition for treating coronary heart disease |
CN111870645A (en) * | 2020-07-09 | 2020-11-03 | 何庆勇 | Composition for treating coronary heart disease, traditional Chinese medicine composition and application thereof |
-
2023
- 2023-06-13 CN CN202310695231.8A patent/CN116617328A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105832978A (en) * | 2016-04-21 | 2016-08-10 | 北京祥和康健科技发展有限公司 | Traditional Chinese medicine composition for treating coronary heart disease |
CN111870645A (en) * | 2020-07-09 | 2020-11-03 | 何庆勇 | Composition for treating coronary heart disease, traditional Chinese medicine composition and application thereof |
Non-Patent Citations (1)
Title |
---|
魏希进: "桂枝汤类方治疗冠心病举隅", 山东中医杂志, vol. 29, no. 08, 5 August 2010 (2010-08-05), pages 569 - 570 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116270885A (en) * | 2023-05-11 | 2023-06-23 | 中国人民解放军陆军第八十二集团军医院 | Traditional Chinese medicine composition for treating phlegm stagnation type coronary heart disease and application thereof |
CN116270885B (en) * | 2023-05-11 | 2024-06-07 | 中国人民解放军陆军第八十二集团军医院 | Traditional Chinese medicine composition for treating phlegm stagnation type coronary heart disease and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102205107B (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
CN102755596B (en) | Traditional Chinese medicine for treating phlegm-dampness hyperplasia of mammary glands and preparation method thereof | |
CN107693767A (en) | A kind of external medicine composition, its preparation method and application for preventing and treating diabetes | |
CN116617328A (en) | Traditional Chinese medicine composition for treating coronary heart disease stable angina pectoris phlegm-blood stasis syndrome | |
CN105596777A (en) | Traditional Chinese medicine for dredging blood vessels and reducing blood pressure | |
CN103638475B (en) | A kind of medicinal herb spray for the treatment of nodules of the breast and preparation method thereof | |
CN105596861A (en) | Pill used for treating adverse reaction after CT enhancement scanning and preparation method | |
CN110038111A (en) | A kind of Chinese herbal ointment formula preparation and preparation method thereof for treating atrophic gastritis | |
CN114767794B (en) | Traditional Chinese medicine for treating arterial plaque | |
CN112023010A (en) | Traditional Chinese medicine composition for slimming, preparation method thereof, oral medicine and application | |
CN104758754A (en) | Medicine for treating kidney qi deficiency benign prostate hyperplasia and preparation method thereof | |
CN104623057A (en) | Pharmaceutical composition for treating diabetic feet and application pf pharmaceutical composition | |
CN104189615B (en) | Traditional Chinese medicine preparation for treating metrorrhagia and metrostaxis, and preparation method of traditional Chinese medicine preparation | |
CN113144080B (en) | Traditional Chinese medicine for treating coronary atherosclerotic plaques | |
CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
CN107854662A (en) | A kind of Chinese medicine preparation for treating cirrhotic ascites and preparation method thereof | |
CN106668390B (en) | Traditional Chinese medicine composition for treating hyperthyroidism in early and middle stages | |
CN106822852A (en) | Treat pharmaceutical composition, its preparation technology and the purposes of coronary heart disease | |
CN106728835A (en) | A kind of Chinese medicine for treating diabetes | |
CN1170555C (en) | Chinese patent medicine for treating ulcer diseases | |
CN117211107A (en) | Traditional Chinese medicine rice paper with physiotherapy effect and preparation method thereof | |
CN109528906A (en) | It is a kind of for treating the Chinese materia medica preparation and preparation method thereof of tubal occlusion and adhesion | |
CN103356984B (en) | Traditional Chinese medicine composition for preventing and treating female iron deficiency anemia | |
CN113398225A (en) | Traditional Chinese medicine for alcoholic hepatic fibrosis | |
CN110652540A (en) | Formula for treating food retention type diabetes and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20230822 |